Europe Muscle Relaxant Drugs Market

Europe Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

Report Id: KBV-15578 Publication Date: May-2023 Number of Pages: 82
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Muscle Relaxant Drugs Market, by Drug Type
1.4.2 Europe Muscle Relaxant Drugs Market, by Route of Administration
1.4.3 Europe Muscle Relaxant Drugs Market, by Distribution Channel
1.4.4 Europe Muscle Relaxant Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Europe Muscle Relaxant Drugs Market by Drug Type
3.1 Europe Skeletal Market by Country
3.2 Europe Neuromuscular Blocking Agents Market by Country
3.3 Europe Facial Muscle Relaxant Drugs Market by Country

Chapter 4. Europe Muscle Relaxant Drugs Market by Route of Administration
4.1 Europe Oral Market by Country
4.2 Europe Injectable Market by Country

Chapter 5. Europe Muscle Relaxant Drugs Market by Distribution Channel
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacies Market by Country

Chapter 6. Europe Muscle Relaxant Drugs Market by Country
6.1 Germany Muscle Relaxant Drugs Market
6.1.1 Germany Muscle Relaxant Drugs Market by Drug Type
6.1.2 Germany Muscle Relaxant Drugs Market by Route of Administration
6.1.3 Germany Muscle Relaxant Drugs Market by Distribution Channel
6.2 UK Muscle Relaxant Drugs Market
6.2.1 UK Muscle Relaxant Drugs Market by Drug Type
6.2.2 UK Muscle Relaxant Drugs Market by Route of Administration
6.2.3 UK Muscle Relaxant Drugs Market by Distribution Channel
6.3 France Muscle Relaxant Drugs Market
6.3.1 France Muscle Relaxant Drugs Market by Drug Type
6.3.2 France Muscle Relaxant Drugs Market by Route of Administration
6.3.3 France Muscle Relaxant Drugs Market by Distribution Channel
6.4 Russia Muscle Relaxant Drugs Market
6.4.1 Russia Muscle Relaxant Drugs Market by Drug Type
6.4.2 Russia Muscle Relaxant Drugs Market by Route of Administration
6.4.3 Russia Muscle Relaxant Drugs Market by Distribution Channel
6.5 Spain Muscle Relaxant Drugs Market
6.5.1 Spain Muscle Relaxant Drugs Market by Drug Type
6.5.2 Spain Muscle Relaxant Drugs Market by Route of Administration
6.5.3 Spain Muscle Relaxant Drugs Market by Distribution Channel
6.6 Italy Muscle Relaxant Drugs Market
6.6.1 Italy Muscle Relaxant Drugs Market by Drug Type
6.6.2 Italy Muscle Relaxant Drugs Market by Route of Administration
6.6.3 Italy Muscle Relaxant Drugs Market by Distribution Channel
6.7 Rest of Europe Muscle Relaxant Drugs Market
6.7.1 Rest of Europe Muscle Relaxant Drugs Market by Drug Type
6.7.2 Rest of Europe Muscle Relaxant Drugs Market by Route of Administration
6.7.3 Rest of Europe Muscle Relaxant Drugs Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Amneal Pharmaceuticals, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.2 Ipsen Pharma Biotech SAS
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Merz Pharma GmbH & Co. KGaA
7.3.1 Company Overview
7.4 Mallinckrodt PLC
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Teva Pharmaceutical Industries Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.6 Eisai Co., Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Endo International PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Research & Development Expense
7.8 Vertical Pharmaceuticals, LLC
7.8.1 Company Overview
7.9 SteriMax Inc.
7.9.1 Company Overview
7.10. Metacel Pharmaceuticals, LLC.
7.10.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo